JAZZ PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHFri, 24 Apr 2026 12:30:50 +0200https://images.finanzen.net/images/finanzen_net_neu.gifJAZZ PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netJazz Pharmaceuticals hat die Zahlen zum jüngsten Quartal vorgelegtThu, 26 Feb 2026 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-hat-die-zahlen-zum-juengsten-quartal-vorgelegt-15517833Jazz Pharmaceuticals lud am 24.02.2026 zur Finanzkonferenz und hat dort die Zahlen zum am 31.12.2025 abgelaufenen Jahresviertel präsentiert.Der Gewinn je Aktie belief sich auf 3,21 USD. Im Vorjahresviertel ...

]]>https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-hat-die-zahlen-zum-juengsten-quartal-vorgelegt-15517833Ausblick: Jazz Pharmaceuticals verkündet Quartalsergebnis zum jüngsten JahresviertelMon, 23 Feb 2026 07:01:06 +0100https://www.finanzen.net/nachricht/aktien/ausblick-jazz-pharmaceuticals-verkuendet-quartalsergebnis-zum-juengsten-jahresviertel-15508750Jazz Pharmaceuticals gibt am 24.02.2026 die Zahlen für das am 31.12.2025 abgelaufene Quartal bekannt.In Sachen EPS gehen 14 Analysten von einem durchschnittlichen Gewinn von 6,52 USD je Aktie aus. Im ...

]]>https://www.finanzen.net/nachricht/aktien/ausblick-jazz-pharmaceuticals-verkuendet-quartalsergebnis-zum-juengsten-jahresviertel-15508750Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business OfficerThu, 08 Jan 2026 22:05:00 +0100https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-appoints-thomas-riga-as-chief-business-officer-15403686

Mr. Riga brings over 25 years of commercial and operational experience with proven success leading transformative corporate development strategies and transactions

]]>https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-appoints-thomas-riga-as-chief-business-officer-15403686Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival BenefitTue, 06 Jan 2026 19:32:00 +0100https://www.finanzen.net/nachricht/aktien/ziihera-zanidatamab-hrii-combinations-achieve-unprecedented-results-in-first-line-her2-locally-advanced-or-metastatic-gea-including-more-than-two-years-median-overall-survival-benefit-15396669

Positive Phase 3 HERIZON-GEA-01 results support Ziihera as the HER2-targeted agent-of-choice in HER2+ first-line metastatic GEA and Ziihera plus chemotherapy to replace trastuzumab ...

]]>https://www.finanzen.net/nachricht/aktien/ziihera-zanidatamab-hrii-combinations-achieve-unprecedented-results-in-first-line-her2-locally-advanced-or-metastatic-gea-including-more-than-two-years-median-overall-survival-benefit-15396669Jazz Pharmaceuticals to Participate in Upcoming Investor EventsWed, 17 Dec 2025 22:15:00 +0100https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-participate-in-upcoming-investor-events-15366456

DUBLIN, Dec. 17, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the ...

]]>https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-participate-in-upcoming-investor-events-15366456Jazz Pharmaceuticals to Participate in Upcoming Investor EventsWed, 17 Dec 2025 22:15:00 +0100https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-participate-in-upcoming-investor-events-15366462

DUBLIN, Dec. 17, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the ...

]]>https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-participate-in-upcoming-investor-events-15366462Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 An...Fri, 05 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-present-extensive-new-data-and-real-world-evidence-highlighting-epidiolex-cannabidiol-outcomes-in-treatment-resistant-epilepsies-at-the-american-epilepsy-society-2025-an-15338657

New interim results from the EpiCom trial, a prospective evaluation of behavioral outcomes in patients with tuberous sclerosis complex, suggest improvements in non-seizure outcomes

]]>https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-present-extensive-new-data-and-real-world-evidence-highlighting-epidiolex-cannabidiol-outcomes-in-treatment-resistant-epilepsies-at-the-american-epilepsy-society-2025-an-15338657Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at th...Tue, 02 Dec 2025 22:05:00 +0100https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-present-pivotal-phase-3-results-of-ziihera-zanidatamab-hrii-combinations-in-first-line-her2-positive-locally-advanced-or-metastatic-gastroesophageal-adenocarcinoma-at-th-15329824

Late-breaking HERIZON-GEA-01 presentation highlights the expanding clinical profile of Ziihera across HER2-driven gastrointestinal cancers

Jazz ...

]]>https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-present-pivotal-phase-3-results-of-ziihera-zanidatamab-hrii-combinations-in-first-line-her2-positive-locally-advanced-or-metastatic-gastroesophageal-adenocarcinoma-at-th-15329824Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare ConferenceTue, 18 Nov 2025 22:15:00 +0100https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-participate-in-citi-s-2025-global-healthcare-conference-15289694

DUBLIN, Nov. 18, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the ...

]]>https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-participate-in-citi-s-2025-global-healthcare-conference-15289694Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare ConferenceTue, 18 Nov 2025 22:15:00 +0100https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-participate-in-citi-s-2025-global-healthcare-conference-15289699

DUBLIN, Nov. 18, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the ...

]]>https://www.finanzen.net/nachricht/aktien/jazz-pharmaceuticals-to-participate-in-citi-s-2025-global-healthcare-conference-15289699